This episode is a rebroadcast of the ACCP Cardiology PRN webinar where Drs. Tracy Macaulay and Bill Larsen reviewed the REDUCE-AMI and EMPACT-MI trials released at the ACC 24 meeting.
0:00-2:19: Introduction
2:05-9:24: The REDUCE-AMI Trial
9:25-14:19: The EMPACT-MI Trial
14:20-17:58: Questions
17:59-18:36: Closing thoughts
References:
REDUCE-AMI
Yndigegn T, Lindahl B, Mars K, et al. Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction. N Engl J Med. 2024;390(15):1372-1381. doi:10.1056/NEJMoa2401479
EMPACT-MI
Butler J, Jones WS, Udell JA, et al. Empagliflozin after Acute Myocardial Infarction. N Engl J Med. 2024;390(16):1455-1466. doi:10.1056/NEJMoa2314051
